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a b s t r a c t
Gingival hypertrophy (GH) is a well-known physical manifestation due to inﬂammatory
conditions, pregnancy, vitamin C deﬁciency, systemic diseases like leukemia, Wegners
granulomatosis, and various drugs like anticonvulsants, immunosuppresant, and calcium
channel blockers (CCBs).We present here a case of a 45-year-old woman, who has been
taking Amlodipine 10 mg once a day together with Atenelol 50 mg per day for one and half
years, and has subsequently developed gum hypertrophy. This manifestation was reversed
after stopping of Amlodipine. Though this case presentation is described in literature, we
hereby present it in a pictorial form, to sensitize the treating physician toward it.
# 2015 Cardiological Society of India. Published by Elsevier B.V. All rights reserved.[(Fig._1)TD$FIG]1. Case presentationFig. 1 – Gingival swelling and redness.A 45-year-old woman presented with history of gum swellings
and redness for the last 6 months [Fig. 1]. On presentation her
blood pressure was 140/84 mm Hg and the pulse rate was
75 min–1. Her routine blood investigations were normal.
Electrocardiography showed left ventricular hypertrophy.
She has been taking Tablet Amlodipine 10 mg once a day
together with Tablet Atenelol 50 mg per day for one and half
years as prescribed by her physician. Amlodipine was stopped
and the dose of Atenelol was increased to 50 mgQID. Her blood
pressure was stable on this drug. Baseline investigations for
secondary causes of gingival enlargement were done and* Corresponding author. Tel.: +91 9650082899; fax: +91 11 22950495.
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gradually within 4 months.
2. DiscussionGingival hypertrophy due to drugs is termed as ‘‘drug-induced
gingival overgrowth (DIGO)’’.1 Drugs that cause GH are:
anticonvulsants such as phenytoin, phenobarbital, lamotri-
gine, valproate, vigabatrin, ethosuximide, topiramate, primi-
done; and calcium channel blockers such as nifedipine,
amlodipine, verapamil, nifedipine and immunosuppresants
like cyclosporine.
The overall prevalence of GH due to CCBs is 38%, with the
prevalence of Amlodipine-inducedGHbeing between 1.7% and
3.3%.2–4 Themale:female ratio is found to be 3.3.4 Although the
exact mechanism is not known, some investigators suggest
that it may be due to inﬂammatory and noninﬂammatory
causes or due to derangements in the drug metabolic
pathway.5 If GH is left untreated, it can cause ulceration,
bleeding, infection, abscess, or difﬁculty in chewing.
This case sheds light on the importance of early detection
of these signs, so that, by instituting appropriate alternate drug
treatment for hypertension, this can be reversed. As this drug
is commonly used and this sign is often missed due to lack ofawareness,we are presenting this case to sensitize the treating
physician toward it.
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